Back to search

Peptide record

TPDB62439

linear (HR)4 Cell-penetrating Peptides standard
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB62439
linear (HR)4
Cell-penetrating Peptides
Delivery and barrier-penetrating peptides
CPPsite3.0
standard
No
A 8-aa standard natural cell-penetrating peptides peptide sequence curated from CPPsite3.0, with an available 3D structural model.
Chemical: Acetic anhydride(C2),Suberic acid (C8), lauric acid (C12), myristic acid (C14), palmitic acid (C16), oleic acid (C18), and arachidic acid (C20)
Sequence
HRHRHRHR
Physicochemical Analysis
C48H78N28O9
ANDCEQGILKMFPSTWYV
RH
1191.33
12.88
8
0
0
+4
7.08
-3.850
0.00
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
4
R
0
N
0
D
0
C
0
E
0
Q
0
G
4
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 4 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
8
C48H78N28O9
1191.33
12.88
+4
7.08
-3.850
Free
Acetic anhydride(C2),Suberic acid (C8), lauric acid (C12), myristic acid (C14), palmitic acid (C16), oleic acid (C18), and arachidic acid (C20)
L
Cationic
Linear
Free
N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)O
Evidence Records 2 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

Sk-Ov-3 And CCRF-CEM Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Cationic
Synthetic
CF-labelled GpYEEI with paclitaxel or gemcitabine
C16-(HR)4 and C20-(HR)4 improved the cellular uptake of CF-GpYEEI by 1.5 and 2.0 folds, C2-(HR)4 and C8-(HR)4 by 10 %, while C12/C14/C18-(HR)4 reduce the cellular uptake.
In vitro
CCC
Evidence 2 Activity

Activity

Cell-penetrating Peptides

Target

Sk-Ov-3 And CCRF-CEM Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Anticancer drugs including (doxorubicin, etoposide, cisplatin, epirubicin, paclitaxel, and gemcitabine)
In vitro
CCSCC
Additional Detail Fields 1 fields
CCC CCSCC